NSE filing, NSE: INDUSTOWER. Summary written from the filing by ALFA Finder's alert engine.
Indus Towers Ltd: key numbers
- Share price
- ₹387.00
- Market cap
- ₹1,02,097 Cr
- Revenue (annual)
- ₹32,493 Cr
- Net profit (annual)
- ₹7,145 Cr
- P/E (TTM)
- 14.4×Sector 38.5×
- Promoter holding
- 51.26%+0.00% QoQ
- FII holding
- 21.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indus Towers Ltd
All →Indus Towers Earnings Call Transcript: Key Takeaways
Indus Towers delivered steady operational growth driven by strong co-location additions and network expansion from a major customer.
Indus Towers Results Update
Indus Towers released its Q2 and half-year quarterly report with audited results. Headline revenue and profit figures are not visible in these pages.
Indus Towers Q2 FY27 Results: Net Profit ₹1,793 Cr, Down 2.5% YoY
Indus Towers Ltd reported revenue from operations of ₹8,516 Cr (+4.0% YoY) and net profit of ₹1,793 Cr (-2.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,793 Cr · -2.5% YoY
Indus Towers Other Announcement
The company submitted its quarterly shareholding pattern for the period ending September 30, 2026, as required by SEBI regulations.
Indus Towers Board Meeting Date
Indus Towers announced a board meeting on October 27, 2026, to consider and approve its audited financial results for the second quarter ended September 30, 2026.
Indus Towers Other Announcement
Indus Towers Limited has been assigned an ESG Rating of 69.86 (Leader) by Niche Ninety Nine Capability and Certifications (OPC) Private Limited.
Other credit rating announcements
All →Purple United Sales Credit Rating
Purple United Sales' credit rating from Crisil was reaffirmed at BBB-/Stable on Rs.175 Crore of bank facilities. The rated facilities were enhanced from Rs.100 Crore.
Pioneer Investcorp Credit Rating
Pioneer Investcorp received an IVR A2+ rating from Informics Valuation and Rating on November 3, 2026. The rating covers its INR 25 Crore commercial paper.
Sahajanand Medical Technologies Credit Rating
CRISIL has upgraded Sahajanand Medical Technologies' long-term bank facility rating to CRISIL A-/Stable from BBB+/Stable. The upgrade reflects improved business risk, growing scale, and sustained profitability across its global stent manufacturing operations.
- Value
- ₹300.0 Cr
Consolidated Construction Consortium Credit Rating
Consolidated Construction Consortium Ltd has withdrawn its credit rating facility provided by ICRA Limited. The company continues to maintain its rating facility with Infomerics Valuation and Rating Ltd.
I G Petrochemicals Credit Rating
India Ratings & Research affirmed and assigned IND AA-/Stable/IND A1+ to IG Petrochemicals' bank loan facilities. The rating signals sustained credit strength for the company's debt instruments.
Bank of Maharashtra Credit Rating
CRISIL reaffirmed its Crisil A1+ rating on Bank of Maharashtra's Certificate of Deposits. No new money is involved, only a rating action on existing securities.